Rivaroxaban-Induced Hair Loss

August 2015 in “ European Journal of Clinical Pharmacology ”

Basile Chrétien, Anne Besnard, Marion Sassier, Antoine Coquerel, Joachim Alexandre, Sophie Fédrizzi

rivaroxaban factor Xa inhibitor anticoagulant hair loss alopecia minoxidil Rogaine

Studysummary This case report suggests that hair loss may be a potential adverse effect of rivaroxaban, though it is not listed in the product characteristics.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden NOAC Registry (NCT01588119)

8 citations , November 2012 in “Blood”

This study observed that the incidence of hair loss as a spontaneously reported side effect of novel oral anticoagulant therapy is approximately 4.4 per 100 patient years.

research Drugs and Hair Loss: Mechanisms and Clinical Implications

54 citations , September 2012 in “Dermatologic Clinics”

This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.

research Telogen Effluvium: Causes, Diagnosis, and Treatment

144 citations , July 2002 in “Clinical and Experimental Dermatology”

This article reviews the concept of telogen effluvium and emphasizes the importance of identifying triggers and using diagnostic investigations to determine the cause of hair loss, without reporting new results.